Our mission is to identify and characterize novel molecular vulnerabilities in myeloid blood cancers that can be targeted for therapeutic intervention, with the long-term goal of improving upon current treatment regimens for these diseases.

 

The Elf Lab has received support from the following:

​

National Institutes of Health/National Heart, Lung, and Blood Institute

American Society of Hematology

Leukemia & Lymphoma Society

Gabrielle's Angel Foundation for Cancer Research/The Mark Foundation for Cancer Research

MPN Research Foundation

National Science Foundation